186 related articles for article (PubMed ID: 23967071)
1. An indirubin derivative, indirubin-3'-monoxime suppresses oral cancer tumorigenesis through the downregulation of survivin.
Lo WY; Chang NW
PLoS One; 2013; 8(8):e70198. PubMed ID: 23967071
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of indirubin-3'-monoxime against human osteosarcoma.
Zhang Y; Song L; Li J; Zhang Y; Lu X; Zhang B
IUBMB Life; 2019 Oct; 71(10):1465-1474. PubMed ID: 31050877
[TBL] [Abstract][Full Text] [Related]
3. Critical role of Bid and Bax in indirubin-3'-monoxime-induced apoptosis in human cancer cells.
Shi J; Shen HM
Biochem Pharmacol; 2008 May; 75(9):1729-42. PubMed ID: 18377873
[TBL] [Abstract][Full Text] [Related]
4. Indirubin-3'-monoxime, a CDK inhibitor induces growth inhibition and apoptosis-independent up-regulation of survivin in transitional cell cancer.
Perabo FG; Frössler C; Landwehrs G; Schmidt DH; von Rücker A; Wirger A; Müller SC
Anticancer Res; 2006; 26(3A):2129-35. PubMed ID: 16827155
[TBL] [Abstract][Full Text] [Related]
5. Antiproliferative and apoptosis inducing effects of indirubin-3'-monoxime in renal cell cancer cells.
Perabo FG; Landwehrs G; Frössler C; Schmidt DH; Mueller SC
Urol Oncol; 2011; 29(6):815-20. PubMed ID: 19945313
[TBL] [Abstract][Full Text] [Related]
6. Eugenol triggers apoptosis in breast cancer cells through E2F1/survivin down-regulation.
Al-Sharif I; Remmal A; Aboussekhra A
BMC Cancer; 2013 Dec; 13():600. PubMed ID: 24330704
[TBL] [Abstract][Full Text] [Related]
7. Indirubin-3'-monoxime promotes autophagic and apoptotic death in JM1 human acute lymphoblastic leukemia cells and K562 human chronic myelogenous leukemia cells.
Lee MY; Liu YW; Chen MH; Wu JY; Ho HY; Wang QF; Chuang JJ
Oncol Rep; 2013 May; 29(5):2072-8. PubMed ID: 23468088
[TBL] [Abstract][Full Text] [Related]
8. Indirubin-3-monoxime and thymoquinone exhibit synergistic efficacy as therapeutic combination in in-vitro and in-vivo models of Lung cancer.
Dera AA; Rajagopalan P; Al Fayi M; Ahmed I; Chandramoorthy HC
Arch Pharm Res; 2020 Jun; 43(6):655-665. PubMed ID: 32588331
[TBL] [Abstract][Full Text] [Related]
9. Indirubin-3'-monoxime induces paraptosis in MDA-MB-231 breast cancer cells by transmitting Ca
Dilshara MG; Neelaka Molagoda IM; Prasad Tharanga Jayasooriya RG; Choi YH; Park C; Kim GY
Arch Biochem Biophys; 2021 Feb; 698():108723. PubMed ID: 33321111
[TBL] [Abstract][Full Text] [Related]
10. Indirubin-3-monoxime exhibits anti-inflammatory properties by down-regulating NF-κB and JNK signaling pathways in lipopolysaccharide-treated RAW264.7 cells.
Kim JK; Park GM
Inflamm Res; 2012 Apr; 61(4):319-25. PubMed ID: 22187016
[TBL] [Abstract][Full Text] [Related]
11. Indirubin-3'-monoxime, a derivative of a chinese antileukemia medicine, inhibits angiogenesis.
Kim JK; Shin EK; Kang YH; Park JH
J Cell Biochem; 2011 May; 112(5):1384-91. PubMed ID: 21337385
[TBL] [Abstract][Full Text] [Related]
12. Rational combinations of indirubin and arylidene derivatives exhibit synergism in human non-small cell lung carcinoma cells.
Rajagopalan P; Dera A; Abdalsamad MR; C Chandramoorthy H
J Food Biochem; 2019 Jul; 43(7):e12861. PubMed ID: 31353710
[TBL] [Abstract][Full Text] [Related]
13. 5'-nitro-indirubinoxime induces G2/M cell cycle arrest and apoptosis in human KB oral carcinoma cells.
Kim SA; Kim SW; Chang S; Yoon JH; Ahn SG
Cancer Lett; 2009 Feb; 274(1):72-7. PubMed ID: 18926623
[TBL] [Abstract][Full Text] [Related]
14. Indirubin-3'-oxime induces mitochondrial dysfunction and triggers growth inhibition and cell cycle arrest in human neuroblastoma cells.
Liao XM; Leung KN
Oncol Rep; 2013 Jan; 29(1):371-9. PubMed ID: 23117445
[TBL] [Abstract][Full Text] [Related]
15. Indirubin-3'-monoxime inhibits autophosphorylation of FGFR1 and stimulates ERK1/2 activity via p38 MAPK.
Zhen Y; Sørensen V; Jin Y; Suo Z; Wiedłocha A
Oncogene; 2007 Sep; 26(44):6372-85. PubMed ID: 17533378
[TBL] [Abstract][Full Text] [Related]
16. Indirubin derivatives inhibit malignant lymphoid cell proliferation.
Chebel A; Kagialis-Girard S; Catallo R; Chien WW; Mialou V; Domenech C; Badiou C; Tigaud I; Ffrench M
Leuk Lymphoma; 2009 Dec; 50(12):2049-60. PubMed ID: 19860623
[TBL] [Abstract][Full Text] [Related]
17. Wogonin induces apoptosis and down-regulates survivin in human breast cancer MCF-7 cells by modulating PI3K-AKT pathway.
Huang KF; Zhang GD; Huang YQ; Diao Y
Int Immunopharmacol; 2012 Feb; 12(2):334-41. PubMed ID: 22182776
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of CRM1: A Characteristic Feature in a Transformed Phenotype of Lung Carcinogenesis and a Molecular Target for Lung Cancer Adjuvant Therapy.
Gao W; Lu C; Chen L; Keohavong P
J Thorac Oncol; 2015 May; 10(5):815-825. PubMed ID: 25629636
[TBL] [Abstract][Full Text] [Related]
19. Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy.
Huang KJ; Kuo CH; Chen SH; Lin CY; Lee YR
J Cell Mol Med; 2018 Mar; 22(3):1894-1908. PubMed ID: 29363886
[TBL] [Abstract][Full Text] [Related]
20. Sensitization of melanoma cells for death ligand-induced apoptosis by an indirubin derivative--Enhancement of both extrinsic and intrinsic apoptosis pathways.
Berger A; Quast SA; Plötz M; Hein M; Kunz M; Langer P; Eberle J
Biochem Pharmacol; 2011 Jan; 81(1):71-81. PubMed ID: 20858462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
